Profound Medical Corp. (PROF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on March 9, 2026. The registrant is incorporated in Ontario, Canada, and its common shares trade on The Nasdaq Stock Market under the symbol "PROF". The report serves as a Regulation FD disclosure regarding an upcoming investor event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The primary disclosure is the announcement of a scheduled investor conference call.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will host an investor conference call on March 13, 2026, at 11:30 a.m. ET.
- Topic: The call will discuss clinical outcomes of the Company's CAPTAIN trial.
- Access: Instructions for accessing the call and an advanced registration link are provided in the press release furnished as Exhibit 99.1.
- Legal Status: The information furnished under Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings.
Investor Verification Checklist
- Verify the date and time of the investor conference call (March 13, 2026, 11:30 a.m. ET).
- Review the press release (Exhibit 99.1) for the advanced registration link to the call.
- Monitor the CAPTAIN trial clinical outcomes discussion during the scheduled call.
- Confirm that no financial data is included in this specific 8-K filing.